Metavesco, Inc. (OTC: MVCO), a diversified holding company and developer of the OTCfi ecosystem, today announced it has executed a Strategic Partnership Agreement with BLAQclouds, Inc. (OTC: BCDS), a leading Web3 infrastructure and blockchain technology company. The partnership establishes long-term collaboration to accelerate Metavesco's token development initiatives and expand community-driven engagement across the OTC ecosystem. […]

Company enters the U.S. market with a mission to make modern, cloud-native imaging accessible to every provider. AdvaHealth Solutions, a global provider of healthcare technology company, today announced its strategic entry into the U.S. market ahead of RSNA 2025. The company also welcomed Imad Nijim, a respected leader in enterprise imaging, to its Board of

(NASDAQ:MGX), EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A, President and Chief Executive Officer of Metagenomi, will be presenting at the Jefferies Global Healthcare

(NASDAQ:EVCM), DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) — EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that Chief Executive Officer Eric Remer and SVP, Finance, & Head of Investor Relations Brad Korch will present and participate in 1×1 meetings at the 2025 RBC Capital Markets Global Technology, Internet,

(NASDAQ:HTLM), SINGAPORE, Nov. 17, 2025 (GLOBE NEWSWIRE) — HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”), a Singapore-based home furniture company with sales across Asia-Pacific, Europe and North America, today announced its unaudited financial results for the nine months ended September 30, 2025 (“9M 2025”) and the third quarter of 2025 (“Q3 2025”). “Our consistent

Metagenomi to Present at Jefferies Global Healthcare Conference in London GlobeNewswire November 17, 2025 EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A, President and

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury. GlobeNewswire November 17, 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd., (Nasdaq:

(PinkSheets:BCDS),(Pinksheets:BCDS),(Other OTC:MVCO), ROBESONIA, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) — BLAQclouds, Inc. (OTC: BCDS), a leading Web3 infrastructure and digital asset technology company, today announced the execution of a Strategic Partnership Agreement with Metavesco, Inc. (OTC: MVCO), a Nevada-based digital asset and blockchain-focused company. Under this partnership, the two firms will collaborate to accelerate token

Aeries Technology featured in Everest Group's PEAK Matrix(R) for GCC Setup Capabilities 2025 for the Second Year Running Recognition highlights Aeries' continued strength in global capability center setup for mid-market and PE-backed enterprises GlobeNewswire November 17, 2025 NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered

Annovis Reports New Biomarker Data Linking Amyloid Co-Pathology to Accelerated Cognitive Decline in Parkinson's Patients GlobeNewswire November 17, 2025 Buntanetap significantly improves cognition in all Parkinson's patients, with those exhibiting Alzheimer's co-pathology showing a three-times greater response New data demonstrate reductions in plasma biomarkers pTau217, total tau, and brain-derived tau following buntanetap treatment Findings support